The major goal of this Program Project Grant (PPG) is to continue to expand and further develop a vigorous research program focused on elucidating the etiology and pathogenesis of frontotemporal dementias (FTDs) tauopathies and other neurodegenerative variants of FTDs. During the last funding cycle, a close-knit and highly integrated multidisciplinary group of investigators formed a productive collaborative alliance and established a very comprehensive clinical and basic science research center-without-walls to study patients with FTDs. During the next funding period of this PPG, these seasoned investigators and young faculty newly recruited to the PPG propose a set of bold new objectives for FTD research that will be implemented through 3 Cores and 4 Projects. Specifically, they will characterize the spectrum of the clinical phenotypes seen in FTD patients, identify new mutations in FTD kindreds, elucidate mechanism of tau fibrillization, determine the building blocks ofubiquitin positive but tau, alpha-synuclein and neurofilament negative inclusions in FTD with or without motor neuron disease, and develop transgenic mouse and Co elegans models with greater versimilitude to human tau pathologies thereby leading to improvements in understanding FTDs as well as the diagnosis and treatment of these disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG017586-10
Application #
7577455
Study Section
Special Emphasis Panel (ZAG1-ZIJ-9 (O4))
Program Officer
Miller, Marilyn
Project Start
2000-03-15
Project End
2011-02-28
Budget Start
2009-04-15
Budget End
2011-02-28
Support Year
10
Fiscal Year
2009
Total Cost
$1,960,885
Indirect Cost
Name
University of Pennsylvania
Department
Pathology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Gibbons, Garrett S; Lee, Virginia M Y; Trojanowski, John Q (2018) Mechanisms of Cell-to-Cell Transmission of Pathological Tau: A Review. JAMA Neurol :
Bergeron, David; Gorno-Tempini, Maria L; Rabinovici, Gil D et al. (2018) Prevalence of amyloid-? pathology in distinct variants of primary progressive aphasia. Ann Neurol 84:729-740
Kovacs, Gabor G; Xie, Sharon X; Robinson, John L et al. (2018) Sequential stages and distribution patterns of aging-related tau astrogliopathy (ARTAG) in the human brain. Acta Neuropathol Commun 6:50
Martini-Stoica, Heidi; Cole, Allysa L; Swartzlander, Daniel B et al. (2018) TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading. J Exp Med 215:2355-2377
Nativio, Raffaella; Donahue, Greg; Berson, Amit et al. (2018) Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease. Nat Neurosci 21:497-505
Olm, Christopher A; McMillan, Corey T; Irwin, David J et al. (2018) Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers. Neuroimage Clin 19:497-506
Portelius, Erik; Olsson, Bob; Höglund, Kina et al. (2018) Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology. Acta Neuropathol 136:363-376
Pottier, Cyril; Zhou, Xiaolai; Perkerson 3rd, Ralph B et al. (2018) Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. Lancet Neurol 17:548-558
Irwin, David J; Xie, Sharon X; Coughlin, David et al. (2018) CSF tau and ?-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders. Neurology 90:e1038-e1046
Ferraro, Pilar M; Jester, Charles; Olm, Christopher A et al. (2018) Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies. Neurobiol Aging 68:85-92

Showing the most recent 10 out of 593 publications